Back to Agenda
Session 1: IMI PREFER - Journey and Motivations
Session Chair(s)
Isabelle Huys, PHARMD, PHD, MPHARM
Professor, KU Leuven, Belgium
Jürgen Kübler, PHD
Owner, Quantitative Scientific Consulting, Germany
Session 1: IMI PREFER - Journey and Motivations
Speaker(s)
Axel Mühlbacher
Professorship in Health Economics and Medical Management, University of Applied Sciences Neubrandenburg, Germany
What are Patient Preferences? Previous work on Landscape Setting and Projects’ collection: what is happening right now? The Value of PPS
Kevin Marsh, PHD, MSC
Vice President, Patient-Centered Research, Evidera, United Kingdom
What are Patient Preferences? Previous work on Landscape Setting and Projects’ collection: what is happening right now? The Value of PPS
Rebecca Noel, DrPH, MPH
Executive Director, Benefit-Risk Assessment, Eli Lilly, United States
Why is there a need for a Project like PREFER?
Sheila Dickinson, MSC
Director, Patient Experience Data Science, Novartis Pharma AG, Switzerland
How is PREFER bridging the gap?
Have an account?